Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429907 · ClinicalTrials.gov registry record · NA
An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer
A NA study of Malignant Neoplasm of Breast, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT03429907 is a NA study of Malignant Neoplasm of Breast that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 62 participants, above the 55-participant average among 10 other Malignant Neoplasm of Breast trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03429907, a NA study of Malignant Neoplasm of Breast, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn if starting a stress-reduction program before treatment can affect your stress, mood, and physical symptoms during and after treatment for cancer. This is an investigational study. Up to 140 participants will be enrolled in this study. All participants will be recruited at MD Anderson.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Mind-Body Exercises
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03429907
The ClinicalTrials.gov registry entry for NCT03429907 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 55-participant average among 10 other Malignant Neoplasm of Breast trials with a reported enrollment target (13% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Neoplasm of Breast appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03429907 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03429907 about?
NCT03429907 is a clinical study titled "An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer". The goal of this research study is to learn if starting a stress-reduction program before treatment can affect your stress, mood, and physical symptoms during and after treatment for cancer. This is an investigational study. Up to 140 participants will be enrolled in this study. All participants w...
What is the current status of trial NCT03429907?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2017-12-05. Estimated completion is 2026-04-30.
What conditions does trial NCT03429907 study?
This clinical trial studies the following conditions: Malignant Neoplasm of Breast.
What interventions are being tested in trial NCT03429907?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Mind-Body Exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT03429907?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03429907 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm of Breast
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
RECRUITING · NA
-
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
RECRUITING · NA
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
COMPLETED · NA
-
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer
RECRUITING · Phase 1
-
Selumetinib and Olaparib in Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.